Coherus Oncology, Inc. Common Stock
CHRS
CHRS
163 hedge funds and large institutions have $536M invested in Coherus Oncology, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 65 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
163
Holders Change
+2
Holders Change %
+1.24%
% of All Funds
2.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
46
Reduced
65
Closed
18
Calls
$1.04M
Puts
$372K
Net Calls
+$669K
Net Calls Change
+$750K
Top Buyers
Top Sellers
| 1 |
1
State Street
Boston,
Massachusetts
|
$41.7M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$40.9M |
| 3 |
3
Ameriprise
Minneapolis,
Minnesota
|
$9.36M |
| 4 |
4
Millennium Management
New York
|
$1.49M |
| 5 |
5
Nuveen Asset Management
Chicago,
Illinois
|
$1.2M |
